![Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ](https://www.bmj.com/content/bmj/377/bmj-2022-071113/F1.large.jpg)
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ
![4ª DOSE ESTARÁ LIBERADA PARA PESSOAS A PARTIR DE 18 ANOS – |^|^| Estância Climática de Santa Rita do Passa Quatro – SP |^|^ 4ª DOSE ESTARÁ LIBERADA PARA PESSOAS A PARTIR DE 18 ANOS – |^|^| Estância Climática de Santa Rita do Passa Quatro – SP |^|^](https://www.santaritadopassaquatro.sp.gov.br/portal/wp-content/uploads/2022/08/c8d7f8ec-f872-489b-9a87-106800d1c845.jpg)
4ª DOSE ESTARÁ LIBERADA PARA PESSOAS A PARTIR DE 18 ANOS – |^|^| Estância Climática de Santa Rita do Passa Quatro – SP |^|^
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675.jpg)